EHMT1 Antikörper

Produktnummer ABIN1843730

Produktdetails anti-EHMT1 Antikörper

Target: EHMT1 (Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser EHMT1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Aufreinigung: Purified antibody

Immunogen: Purified recombinant fragment of GLP expressed in E. Coli.

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1.0 mg/mL

Buffer: PBS containing 0.03 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.

Details zu EHMT1

Target: EHMT1 (Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1))

Andere Bezeichnung: GLP (EHMT1 Produkte)

Synonyme: EUHMTASE1 antikoerper, Eu-HMTase1 antikoerper, FP13812 antikoerper, GLP antikoerper, GLP1 antikoerper, KMT1D antikoerper, bA188C12.1 antikoerper, EHMT1 antikoerper, G9a antikoerper, 9230102N17Rik antikoerper, D330003E03 antikoerper, mKIAA1876 antikoerper, bZ1O1.6 antikoerper, si:rp71-1o1.6 antikoerper, zgc:136244 antikoerper, euchromatic histone lysine methyltransferase 1 antikoerper, histone-lysine N-methyltransferase EHMT2 antikoerper, euchromatic histone-lysine N-methyltransferase 1 antikoerper, euchromatic histone methyltransferase 1 antikoerper, euchromatic histone-lysine N-methyltransferase 1a antikoerper, EHMT1 antikoerper, Ehmt1 antikoerper, LOC100121084 antikoerper, ehmt1 antikoerper, ehmt1a antikoerper

Hintergrund: Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from enteroendocrine L cells in response to ingested nutrients. The closely related peptides glucagon-like peptide (GLP-1) and glucagon have opposing effects on blood glucose. GLP-1 induces glucose-dependent insulin secretion in the pancreas, while glucagon stimulates gluconeogenesis and glycogenolysis in the liver. Glucagon is processed from a large precursor, proglucagon, in a tissue-specific manner in pancreatic alpha cells. The identification of a hybrid peptide acting as both a GLP-1 agonist and a glucagon antagonist would provide a novel approach for the treatment of type 2 diabetes.

Molekulargewicht: 20 kDa

Gen-ID: 79813

UniProt: P01275